Hernández-MartínA, Kennedy-BatallaR, CañedoE, et al.Imbalance in T-helper 17 cells and targeted therapy in an infant with SAM-like Syndrome. N Engl J Med. 2019; 381(22):2176–2178.
2.
BlairHA. Secukinumab: A review in moderate to severe pediatric plaque psoriasis. Paediatr Drugs. 2021; 23(6):601–608.
3.
López-SánchezC, FallaLM, Roé-CrespoE, et al.Excellent response to secukinumab in an infant with severe generalized pustular psoriasis. J Dermatol. 2021; 48(6):907–910.
4.
PallerAS, CzarnowickiT, Renert-YuvalY, et al.The spectrum of manifestations in desmoplakin gene (DSP) spectrin repeat 6 domain mutations: Immunophenotyping and response to ustekinumab. J Am Acad Dermatol. 2018; 78(3):498–505.e2.
5.
FrommherzLH, SchemppCM, HasC. Secukinumab for the treatment of SAM syndrome associated with desmoglein-1 deficiency. Br J Dermatol. 2021; 184(4):770–772.
